Skip Navigation


Nucleic Acids Research Advance Access originally published online on August 28, 2007
Nucleic Acids Research 2007 35(18):5995-6003; doi:10.1093/nar/gkm647
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (2600K) Freely available
Right arrow Screen PDF (500K) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
35/18/5995    most recent
gkm647v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Sahashi, K.
Right arrow Articles by Ohno, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sahashi, K.
Right arrow Articles by Ohno, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2007, Vol. 35, No. 18 5995-6003
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


RNA

In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites

Kentaro Sahashi1,2, Akio Masuda1, Tohru Matsuura1, Jun Shinmi1, Zhujun Zhang3, Yasuhiro Takeshima3, Masafumi Matsuo3, Gen Sobue2 and Kinji Ohno1,*

1Division of Neurogenetics and Bioinformatics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 2Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya and 3Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan

*To whom correspondence should be addressed. Tel: +81-52-744-2446; Fax: +81-52-744-2449; Email: ohnok{at}med.nagoya-u.ac.jp

Received April 5, 2007. Revised August 6, 2007. Accepted August 6, 2007.

We have found that two previously reported exonic mutations in the PINK1 and PARK7 genes affect pre-mRNA splicing. To develop an algorithm to predict underestimated splicing consequences of exonic mutations at the 5' splice site, we constructed and analyzed 31 minigenes carrying exonic splicing mutations and their derivatives. We also examined 189 249 U2-dependent 5' splice sites of the entire human genome and found that a new variable, the SD-Score, which represents a common logarithm of the frequency of a specific 5' splice site, efficiently predicts the splicing consequences of these minigenes. We also employed the information contents (Ri) to improve the prediction accuracy. We validated our algorithm by analyzing 32 additional minigenes as well as 179 previously reported splicing mutations. The SD-Score algorithm predicted aberrant splicings in 198 of 204 sites (sensitivity = 97.1%) and normal splicings in 36 of 38 sites (specificity = 94.7%). Simulation of all possible exonic mutations at positions –3, –2 and –1 of the 189 249 sites predicts that 37.8, 88.8 and 96.8% of these mutations would affect pre-mRNA splicing, respectively. We propose that the SD-Score algorithm is a practical tool to predict splicing consequences of mutations affecting the 5' splice site.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.